Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC
Clinical trial NCT04609540 · UNKNOWN
Trial details
- NCT number
- NCT04609540
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2021-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.